Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy

Academic Radiology

Volumn 11, Issue 10, 2004, Pages 1115-1124

  Chen, Xiaoming ^a,b   Moore, Mark O ^c   Lehman, Constance D ^a,b   Mankoff, David A ^a,b   Lawton, Thomas J ^b   Peacock, Sue ^a,b   Schubert, Erin K ^b   Livingston, Robert B ^a,b  

^a SEATTLE CANCER CARE ALLIANCE   (United States)

^b Department of Radiology ^*

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Locally advanced breast cancer (LABC); magnetic resonance imaging (MRI); neoadjuvant chemotherapy; positron emission tomography (PET)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ARTICLE; BREAST CARCINOMA; BREAST EXAMINATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HUMAN; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT CARE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; STANDARDIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 7644243565     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2004.07.007     Document Type: Article

References (46)

1. S.M. Swain, M.E. Lippman Systemic therapy of locally advanced breast cancer review and guidelines Oncology (Huntingt) 3 1989 321 328 discussion 28-30, 34
2. O.H. Beahrs Staging of cancer CA Cancer J Clin 41 1991 121 125
3. G.N. Hortobagyi Comprehensive management of locally advanced breast cancer Cancer 66 1990 1387 1391
4. S.M. Swain, R.A. Sorace, C.S. Bagley Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer Cancer Res 47 1987 3889 3894
5. I.E. Smith, G. Walsh, A. Jones High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer J Clin Oncol 13 1995 424 429
6. S. Huber, M. Wagner, I. Zuna, M. Medl, H. Czembirek, S. Delorme Locally advanced breast carcinoma evaluation of mammography in the prediction of residual disease after induction chemotherapy Anticancer Res 20 2000 553 558
7. J. Herrada, R.B. Iyer, E.N. Atkinson, N. Sneige, A.U. Buzdar, G.N. Hortobagyi Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma Clin Cancer Res 3 1997 1565 1569
8. M.A. Helvie, L.K. Joynt, R.L. Cody, L.J. Pierce, D.D. Adler, S.D. Merajver Locally advanced breast carcinoma accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy Radiology 198 1996 327 332
9. S.J. Vinnicombe, A.D. MacVicar, R.L. Guy Primary breast cancer mammographic changes after neoadjuvant chemotherapy, with pathologic correlation Radiology 198 1996 333 340
10. L. Pierce, D. Adler, M. Helvie, A. Lichter, S. Merajver The use of mammography in breast preservation in locally advanced breast cancer Int J Radiat Oncol Biol Phys 34 1996 571 577
11. E.L. Rosen, K.L. Blackwell, J.A. Baker Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy AJR Am J Roentgenol 181 2003 1275 1282
12. L. Martincich, F. Montemurro, S. Cirillo Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy Radiol Med (Torino) 106 2003 51 58
13. K. Wasser, H.P. Sinn, C. Fink Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy Eur Radiol 13 2003 1213 1223
14. S.C. Partridge, J.E. Gibbs, Y. Lu, L.J. Esserman, D. Sudilovsky, N.M. Hylton Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy AJR Am J Roentgenol 179 2002 1193 1199
15. P. Belli, M. Romani, M. Costantini Role of magnetic resonance imaging in the pre and postchemotherapy evaluation in locally advanced breast carcinoma Rays 27 2002 279 290
16. A. Rieber, H.J. Brambs, A. Gabelmann, V. Heilmann, R. Kreienberg, T. Kuhn Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy Eur Radiol 12 2002 1711 1719
17. C. Balu-Maestro, C. Chapellier, A. Bleuse, I. Chanalet, C. Chauvel, R. Largillier Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI Breast Cancer Res Treat 72 2002 145 152
18. L. Esserman, E. Kaplan, S. Partridge MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer Ann Surg Oncol 8 2001 549 559
19. P.T. Weatherall, G.F. Evans, G.J. Metzger, M.H. Saborrian, A.M. Leitch MRI vs. histologic measurement of breast cancer following chemotherapy comparison with x-ray mammography and palpation J Magn Reson Imaging 13 2001 868 875
20. G. Trecate, E. Ceglia, F. Stabile Locally advanced breast cancer treated with primary chemotherapy comparison between magnetic resonance imaging and pathologic evaluation of residual disease Tumori 85 1999 220 228
21. D.C. Abraham, R.C. Jones, S.E. Jones Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging Cancer 78 1996 91 100
22. B. Kurtz, C. Achten, W. Audretsch, M. Rezai, P. Urban, G. Zocholl MR-mammography assessment of tumor response after neoadjuvant radiochemotherapy of locally advanced breast carcinoma [in German] Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 164 1996 469 474
23. R. Gilles, J.M. Guinebretiere, C. Toussaint Locally advanced breast cancer contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy Radiology 191 1994 633 638
24. M.V. Knopp, G. Brix, H.J. Junkermann, H.P. Sinn MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy Magn Reson Imaging Clin N Am 2 1994 633 658
25. N.C. Krak, J.J. van der Hoeven, O.S. Hoekstra, J.W. Twisk, E. van der Wall, A.A. Lammertsma Measuring [(18)F]FDG uptake in breast cancer during chemotherapy comparison of analytical methods Eur J Nucl Med Mol Imaging 30 2003 674 681
26. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy J Nucl Med 44 2003 1806 1814
27. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow Blood flow and metabolism in locally advanced breast cancer relationship to response to therapy J Nucl Med 43 2002 500 509
28. R. Tiling, R. Linke, M. Untch 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy a comparative study Eur J Nucl Med 28 2001 711 720
29. I.C. Smith, A.E. Welch, A.W. Hutcheon Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy J Clin Oncol 18 2000 1676 1688
30. M. Schelling, N. Avril, J. Nahrig Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 2000 1689 1695
31. D.A. Mankoff, L.K. Dunnwald, J.R. Gralow, G.K. Ellis, M.J. Drucker, R.B. Livingston Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography Cancer 85 1999 2410 2423
32. H. Young, R. Baum, U. Cremerius European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography review and 1999 EORTC recommendations Eur J Cancer 35 1999 1773 1782
33. P. Bassa, E.E. Kim, T. Inoue Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer J Nucl Med 37 1996 931 938
34. R.L. Wahl, K. Zasadny, M. Helvie, G.D. Hutchins, B. Weber, R. Cody Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography initial evaluation J Clin Oncol 11 1993 2101 2111
35. P.B. Hathaway, D.A. Mankoff, K.R. Maravilla Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer preliminary experience Radiology 210 1999 807 814
36. American College of Radiology ACR BI-RADS - Magnetic Resonance Imaging ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas 2003 American College of Radiology Reston, VA
37. T.K. Lewellen, S. Kohlmyer, R. Miyaoka, S. Schubert, C. Stearns Investigation of the count rate performance of the General Electric ADVANCE positron emission tomograph IEEE Trans Nucl Sci 42 1995 1051 1057
38. K. Hamacher, H.H. Coenen, G. Stocklin Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution J Nucl Med 27 2 1986 235 238 Feb
39. P. Therasse, S.G. Arbuck, E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216
40. K. James, E. Eisenhauer, M. Christian Measuring response in solid tumors unidimensional versus bidimensional measurement J Natl Cancer Inst 91 1999 523 528
41. World Health Organization WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48 1979 World Health Organization Geneva, Switzerland
42. H. Young, R. Baum, U. Cremerius European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography review and 1999 EORTC recommendations Eur J Cancer 35 1999 1773 1782
43. E.R. Fisher, J. Wang, J. Bryant, B. Fisher, E. Mamounas, N. Wolmark Pathobiology of preoperative chemotherapy findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18 Cancer 95 2002 681 695
44. L.D. Feldman, G.N. Hortobagyi, A.U. Buzdar, F.C. Ames, G.R. Blumenschein Pathological assessment of response to induction chemotherapy in breast cancer Cancer Res 46 1986 2578 2581
45. M.R. Machiavelli, A.O. Romero, J.E. Perez Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma Cancer J Sci Am 4 1998 125 131
46. th Scientific Assembly and Annual Meeting. 2003.